ArticleExploration (Beijing, China)2022

Brain co-delivery of first-line chemotherapy drug and epigenetic bromodomain inhibitor for multidimensional enhanced synergistic glioblastoma therapy.

Yanjie Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.